Litcius/Paper detail

Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study

Péter Mandl, Selma Tobudic, H. Haslacher, Thomas Karonitsch, Daniel Mrak, Thomas Nothnagl, Thomas Perkmann, Helga Radner, Judith Sautner, Elisabeth Simader, Florian Winkler, Heinz Burgmann, Daniel Aletaha, Stefan Winkler, Stephan Blüml

2022Annals of the Rheumatic Diseases19 citationsDOI

Topics & Concepts

MedicineImmunologyRegimenVaccinationProspective cohort studyCoronavirus disease 2019 (COVID-19)CohortSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Rheumatic diseaseHydroxychloroquineCohort studyDiseaseRheumatoid arthritisInternal medicineInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchRheumatoid Arthritis Research and TherapiesCOVID-19 Clinical Research Studies
Response to SARS-CoV-2 vaccination in systemic autoimmune rheumatic disease depends on immunosuppressive regimen: a matched, prospective cohort study | Litcius